Image

Global Aptamers Market – Industry Trends and Forecast to 2030

Healthcare

Image

Global Aptamers Market – Industry Trends and Forecast to 2030

  • Healthcare
  • Upcoming Report
  • Oct 2023
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

Global Aptamers Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 162.00 Million
Diagram Market Size (Forecast Year) USD 1458.00 Million
Diagram CAGR %

Global Aptamers Market, By Type (DNA-Based Aptamers, RNA-Based Aptamers and XNA-Based Aptamers), Application (Diagnostics, Therapeutics Development, Research and Development and Other Applications), Technology (SELEX, and Other Technologies), End Users (Academic and Government Research Institutes, Biotechnology and Pharmaceutical Companies, Contract Research Organizations and Other End Users) – Industry Trends and Forecast to 2030.

Aptamers Market

Aptamers Market Analysis and Size

Aptamers are single-stranded DNA and RNA molecules that can selectively bind to a specific target. Aptamers can be found in a variety of shapes due to their tendency to form helices and also single-stranded loops. These are quickly generated and applied in the inhibition and characterization of proteins and further can be engineered to have higher specificity and affinity. These molecules are versatile in nature which are used to bind targets including proteins, peptides, small molecules, toxins, carbohydrates, and even live cells. Aptamers are usually created by a selection process from a large random sequence pool and they, in turn, can be used for both clinical and research purposes.

Data Bridge Market Research analyses that the global aptamers market which was USD 162 million in 2022, is expected to reach USD 1458 billion by 2030, and is expected to undergo a CAGR of 20.16% during the forecast period 2023-2030. This indicates that the market value. “DNA-Based Aptamers” dominates the product segment of the global aptamers market owing to Low cost and high efficiency of aptamers in binding to large molecules as compared to antibodies coupled with an increased focus to improve the technology In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Aptamers Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Products (Electrosurgical Instruments, Electrosurgical Generators, Plasma and Smoke Management Systems, Electrosurgical Accessories), Surgery (Gynaecological Surgery, Urology Surgery, Cardiovascular Surgery, General Surgery, Neurosurgery, Orthopaedic Surgery, Cosmetic Surgery, Others), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centres, Others), Distribution Channel (Direct, Retail)

Countries Covered

U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of the Middle East & Africa

Market Players Covered

Vivonics Inc. (U.S.), TriLink BioTechnologies (U.S.), SomaLogic, Inc. (U.S.), NeoVentures Biotechnology Inc. (Canada), Base Pair Biotechnologies (U.S.), APTATARGETS SL (Spain), Aptamer Group (U.K.), Aptagen, LLC (U.S.), KANEKA CORPORATION (Japan), IBA GmbH (Germany), AMS Biotechnology (Europe) Limited (U.K.), Creative Biogene (U.S.), Barrick Lab (U.S.), AuramerBio (New Zealand), ATDBio Ltd (U.K.), Donovan Biotechnology, LLC (U.S.), NOVAPTECH (U.S.), 2bind GmbH (Germany), and NOXXON Pharma (Germany)

Market Opportunities

  • Emerging Applications in Therapeutics
  • Point-of-Care Diagnostics

Market Definition

Aptamers are single-stranded DNA and RNA molecules that can selectively bind to a specific target. Aptamers can be found in a variety of shapes due to their tendency to form helices and also single-stranded loops. These are quickly generated and applied in the inhibition and characterization of proteins and further can be engineered to have higher specificity and affinity. These molecules are versatile in nature which are used to bind targets including proteins, peptides, small molecules, toxins, carbohydrates, and even live cells. Aptamers are usually created by a selection process from a large random sequence pool and they, in turn, can be used for both clinical and research purposes.            

Global Aptamers Market Dynamics

Drivers

  • Advancements in SELEX Technology

Systematic Evolution of Ligands by EXponential enrichment (SELEX) technology, used to develop aptamers, has seen significant advancements. These innovations have enhanced the efficiency and specificity of aptamer selection, driving market growth.

  • Increasing Applications in Diagnostics and Therapeutics

Aptamers find applications in diagnostic assays and therapeutic drug development. Their ability to bind to specific targets, including proteins and cells, has led to their use in cancer diagnostics, targeted therapy, and personalized medicine, thereby boosting market demand.

  • Rising Demand for Specific and Sensitive Diagnostic Tool

Aptamers serve as excellent recognition elements in diagnostic assays due to their high specificity and sensitivity. With the growing need for accurate diagnostic tools, aptamers are increasingly being utilized in various diagnostic applications, driving market growth.

Opportunities

  • Emerging Applications in Therapeutics

Aptamers have the potential for therapeutic applications in various diseases, including cardiovascular disorders and infectious diseases. Ongoing research in these areas creates new opportunities for aptamer-based therapies.

  • Point-of-Care Diagnostics

The development of rapid, point-of-care diagnostic tests using aptamers can revolutionize healthcare. Aptamer-based portable diagnostic devices offer opportunities for quick and accurate disease diagnosis, especially in resource-limited settings.

Restraints/Challenges

  • Limited Awareness and Adoption

Despite their potential, aptamers are not as widely adopted as antibodies in various applications. Limited awareness among end-users and healthcare professionals hampers the market growth, as many potential users are not familiar with the technology.

  • Challenges in Large-Scale Production

Large-scale production of high-quality aptamers can be challenging. Maintaining consistency and quality across batches is crucial, and developing cost-effective production methods remains a significant challenge for the market.

This global aptamers market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global aptamers market Contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

  • In December 2020 — SomaLogic, Inc. (US) raised USD 81 million from leading life sciences investors Casdin Capital, Farallon Capital Management, and Foresite Capital. This will support the commercialization of the company’s products in clinical and life science markets
  • In November 2020, SomaLogic, Inc. (US) received funding of USD 121 million to support the expansion and commercialization of its proteomics platform serving the life science and clinical markets

Global Aptamers Market Scope

Global aptamers market is segmented on the basis of type, application, technology, and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

Type

  • DNA-Based Aptamers
  •  RNA-Based Aptamers
  •  XNA-Based Aptamers

Application

  • Diagnostics
  • Therapeutics Development
  •  Research and Development
  •  Other Applications

Technology

  • SELEX
  • Other Technologies

End-User

  • Academic and Government Research Institutes
  •  Biotechnology and Pharmaceutical Companies
  •  Contract Research Organizations
  • Other End Users

Global Aptamers Market Regional Analysis/Insights

The global aptamers market is analysed and market size insights and trends are provided by country, type, application, technology, and end-user as referenced above.

The countries covered in the global aptamers market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America lions the global aptamers market and is expected to continue its trend of dominance during the forecast period. This is because of the prevalence of sophisticated technological base coupled with the increased funding to advance the existing technology. Rising research and development activities too will foster the market growth rate in this region.

Asia-Pacific is expected to show a rapid and lucrative growth rate in the forecast period of 2023 to 2030 owing because of the combined efforts of the market players to tap into untapped markets and developing economies.

The country section of the global aptamers market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.The Aptamers market is analysed and market size insights and trends are provided by country, product, indication and end user as referenced above.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The global aptamers market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global aptamers market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on global aptamers market. The data is available for historic period 2015-2020.

Competitive Landscape and Global Aptamers Market Share Analysis

The global aptamers market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global aptamers market.

Some of the major players operating in the global aptamers market are:

  • Vivonics Inc. (U.S.)
  • TriLink BioTechnologies (U.S.)
  • SomaLogic, Inc. (U.S.)
  • NeoVentures Biotechnology Inc. (Canada)
  • Base Pair Biotechnologies (U.S.)
  • APTATARGETS SL (Spain)
  • Aptamer Group (U.K.)
  • Aptamer Sciences, Inc. (U.S.)
  • Aptagen, LLC (U.S.)
  • KANEKA CORPORATION (Japan)
  • IBA GmbH (Germany)
  • AMS Biotechnology (Europe) Limited (U.K.)
  • Creative Biogene (U.S.)
  • Barrick Lab (U.S.)
  • AuramerBio (New Zealand)
  • ATDBio Ltd (U.K.)
  • Donovan Biotechnology, LLC (U.S.)
  • NOVAPTECH (U.S.)
  • 2bind GmbH (Germany)
  • NOXXON Pharma (Germany)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The Aptamers Market will be worth USD 1458 billion by 2030.
The Aptamers Market growth rate is 20.16% during the forecast period.
Increasing Applications in Diagnostics and Therapeutics & Advancements in SELEX Technology are the growth drivers of the Aptamers Market.
The type, application, technology, and end-user are the factors on which the Aptamers Market research is based.
SomaLogic, Inc. (US) raised USD 81 million from leading life sciences investors Casdin Capital, Farallon Capital Management, and Foresite Capital & SomaLogic, Inc. (US) received funding of USD 121 million to support the expansion and commercialization of its proteomics platform serving the life science and clinical markets are the latest developments in the Aptamers Market.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials